You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Polynitroxylated Pegylated Hemoglobin for Traumatic Brian Injury Resuscitation

    SBC: SYNZYME TECHNOLOGIES LLC            Topic: 102

    DESCRIPTION provided by applicant Traumatic brain injury TBI is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension Vulnerability of TBI patients to hypotension is well recognized and identifies a key need for new approaches The goal of this proposal is to develop to IND a neuroprotective hyper colloid oxygen therapeutic polynit ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. A high resolution and high DQE detector optimized for mammography using single shot bi directional tri contrast imaging

    SBC: SIGRAY, INC.            Topic: NIBIB

    DESCRIPTION provided by applicant X ray tricontrast imaging provides three different modes of contrast absorption contrast the mechanism behind how conventional medical X ray imaging equipment images phase contrast which provides up to X more contrast than absorption based contrast for soft tissue and scatter contrast which provides information of features at dimensions smaller than ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Tuning Germanium Reflectivity and Mosaic

    SBC: AdSem, Inc.            Topic: 90108

    Mosaic crystalline monochromators define performance of neutron scattering devices employed in condensed matter research on research nuclear reactors. This project is devoted to development of a manufacturing technique for slow neutron Germanium mosaic monochromators with reflectivity exceeding reflectivity of pyrolytic graphite crystals. Germanium has small slow neutron absorption; its diamond cr ...

    SBIR Phase II 2016 Department of CommerceNational Institute of Standards and Technology
  4. Automated Access Control Policy Testing System (A-ACPTS)

    SBC: Objectsecurity LLC            Topic: 90302

    A-ACPTS Phase 2 transitions NIST Access Control Policy Tool (ACPT) R&D with innovative enhancements into commercialization, developing a commercially successful access control policy testing product that improves access control policy testing (minimizes error potential, faster, more usable, more efficient). A-ACPTS Phase 2 extends ACPT through a number of innovations that improve testing beyond th ...

    SBIR Phase II 2016 Department of CommerceNational Institute of Standards and Technology
  5. Enhancing Confidentiality of Research Files Based on Medicare Data

    SBC: ACUMEN LLC            Topic: NIA

    DESCRIPTION provided by applicant In the andquot Enhancing Confidentiality of Research Files Based on Medicare Dataandquot project Acumen LLC aims to expand the overall capabilities of researchers to use survey linked Medicare claims data Currently the process for obtaining approval from the Centers for Medicare andamp Medicaid Services CMS to access these files entails significant paper ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Developing small molecule inhibitors of TLR for treatment of rheumatoid arthritis

    SBC: DYNAVAX TECHNOLOGIES CORPORATION            Topic: NIAID

    DESCRIPTION provided by applicant Autoimmune diseases like rheumatoid arthritis RA develop when the immune response targets self antigens leading to inflammation and tissue destruction There is now considerable evidence that recognition of self nucleic acids through toll like receptors TLRs can contribute significantly to sterile inflammation and autoimmunity with the clearest example b ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  7. SMALL MOLECULE THERAPY FOR ALZHEIMER'S DISEASE

    SBC: Recombinant Technologies LLC            Topic: NIA

    DESCRIPTIONprovided by applicantAlzheimer s diseaseADrepresents a progressive degenerative illness that affects the brainresulting in memory impairmentThe complex etiology of AD is not fully resolvedalthough toxic isoforms of amyloidAplaques are strongly implicatedCurrent treatment options are considered to be symptomaticThey are only moderately effective in stabilizing or improving cognitive and ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  8. CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthma

    SBC: IGE THERAPEUTICS, INC.            Topic: NIAID

    DESCRIPTIONprovided by applicantAllergic asthma is a multi faceted inflammatory disease in the lungIgE and Thmediated inflammation play a critical role in extrinsic allergic asthmaOur labs have identified naturally processed IgE cytotoxic peptidesnECPon IgE producing cellswhich serve as CTL vaccineThe feasibility of using nECP with helper peptide PADRE as a universal IgE vaccineor vaccineto treat ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Therapeutic antibody for RSV

    SBC: TRELLIS BIOSCIENCE, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Respiratory syncytial virus RSV is a leading cause of lower respiratory tract disease leading annually to deaths and million hospitalizations of young children worldwide Immune prophylaxis with a monoclonal antibody mAb Synagis tm Medimmune Inc was shown to be effective years ago to reduce complications of infection in premature birth ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Low Cost Instrument free Point of care Platform for Multiplexed Chlamydia Diagnostics

    SBC: Lucira Health, Inc.            Topic: NIAID

    Abstract Chlamydia trachomatis Ct is the most common cause of bacterial sexually transmitted diseases STD with million annual cases worldwide and million U S cases in Most female and male infections are asymptomatic facilitating unchecked transmission that can result in pelvic inflammatory disease infertility chronic pelvic pain and life threatening ectopic pregnancy Ct ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government